Authors

David Mulder

Senior associate

Read More

Christian Dekoninck

Partner

Read More

Dr. Anja Lunze, LL.M.

Partner

Read More

Paul England, DPhil

Senior professional support lawyer

Read More

Agnieszka Sztoldman

Senior associate

Read More
Authors

David Mulder

Senior associate

Read More

Christian Dekoninck

Partner

Read More

Dr. Anja Lunze, LL.M.

Partner

Read More

Paul England, DPhil

Senior professional support lawyer

Read More

Agnieszka Sztoldman

Senior associate

Read More

9 November 2020

Pharmaceutical patent law – 1 of 2 Insights

Pharmaceutical patent law in times of crisis: A comparative study – Part 1

  • Quick read

What is the role of patent law in emergency situations like the current coronavirus pandemic? And what exceptions to the law are there under such circumstances?

In the first article of our two-part series written for the European Intellectual Property Review, our international team consider these questions and more on both a broad, European level and from the perspective of six national jurisdictions.

Read the article here

In this series

Patents & innovation

Pharmaceutical patent law in times of crisis: A comparative study – Part 1

Quick read

by Multiple authors

Patents & innovation

Pharmaceutical patent law in times of crisis: A comparative study – Part 2

Quick read

by Multiple authors

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Capsule in petri dish
Life sciences & healthcare

Has there been a shift in how the European courts approach preliminary injunctions?

19 May 2021
Quick read

by Paul England, DPhil and Christoph de Coster, LL.M. (UC Davis)

Click here to find out more
Androids and facial mapping
Technology, media & communications

AI driven drug design

7 May 2021
Quick read

by Paul England, DPhil

Click here to find out more
Close-Up Of Weight Scale
Patents & innovation

The EU torpedoes itself in cross-border patent disputes

6 May 2021
Briefing

by Paul England, DPhil

Click here to find out more